Dividend Assets Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-130
Closed -$69K 349
2023
Q4
$69K Hold
130
0.01% 236
2023
Q3
$66K Hold
130
0.01% 234
2023
Q2
$68K Hold
130
0.01% 239
2023
Q1
$72K Hold
130
0.02% 234
2022
Q4
$72K Hold
130
0.02% 234
2022
Q3
$66K Hold
130
0.02% 235
2022
Q2
$71K Buy
130
+15
+13% +$8.26K 0.02% 240
2022
Q1
$68K Hold
115
0.01% 263
2021
Q4
$77K Hold
115
0.01% 252
2021
Q3
$66K Buy
115
+65
+130% +$35.7K 0.01% 266
2021
Q2
$25K Hold
50
﹤0.01% 368
2021
Q1
$23K Hold
50
﹤0.01% 376
2020
Q4
$23K Sell
50
-1,200
-96% -$563K ﹤0.01% 366
2020
Q3
$552K Hold
1,250
0.13% 108
2020
Q2
$453K Hold
1,250
0.09% 116
2020
Q1
$355K Hold
1,250
0.09% 118
2019
Q4
$406K Buy
1,250
+50
+4% +$15.2K 0.07% 134
2019
Q3
$350K Hold
1,200
0.06% 136
2019
Q2
$352K Hold
1,200
0.06% 141
2019
Q1
$328K Hold
1,200
0.05% 138
2018
Q4
$269K Hold
1,200
0.05% 144
2018
Q3
$293K Hold
1,200
0.04% 157
2018
Q2
$249K Hold
1,200
0.03% 166
2018
Q1
$248K Hold
1,200
0.01% 160
2017
Q4
$227K Hold
1,200
0.01% 160
2017
Q3
$227K Hold
1,200
0.01% 164
2017
Q2
$209K Buy
+1,200
New +$202K 0.01% 156

Other funds holding TMO

Dividend Assets Capital's TMO Position: Q1 2024 in Review

Dividend Assets Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 130 shares — an estimated $69K sold.

Dividend Assets Capital first reported a position in TMO in Q2 2017 and held it in 27 quarters. The position peaked at $552K in Q3 2020. 2,534 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Dividend Assets Capital reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Dividend Assets Capital sold 130 Thermo Fisher Scientific shares in Q1 2024, an estimated $69K.
  • Dividend Assets Capital first reported a position in Thermo Fisher Scientific in Q2 2017 and held it in 27 quarters.
  • Dividend Assets Capital's Thermo Fisher Scientific position peaked at $552K in Q3 2020.
  • 2,534 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Dividend Assets Capital's 13F filing for Q1 2024, filed 15 May 2024.